A 70-year-old Caucasian man, N.B., presents to your emergency department with dyspnea, peripheral edema, and weight gain. He had a myocardial infarction five years ago and has progressive congestive heart failure (HF) (NYHA Class IV stage D). Currently, BP = 90/60, HR = 78, labs normal except BUN = 48, SrCr = 2 mg/dl, B-type natriuretic peptide = 1100 pg/ml. Physical assessment shows bilateral rales and warm and wet skin turgor. Current medications: furosemide 40 mg q.d., ramipril (Altace, Aventis) 2.5 mg q.d., carvedilol (Coreg, GlaxoSmithKline) 12.5 mg b.i.d., metolazone 2.5 mg p.r.n., weight gain (not taken last month). To treat his acutely decompensated HF and pulmonary edema, his physician prescribes furosemide 40 mg IV x 1. She asks whether to add nesiritide (Natrecor, Scios) or nitroglycerin (NTG) infusion.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.